The global non-opioid pain patches market is poised for substantial growth, with sales projected to exceed US$ 3.3 billion in 2022 and anticipated to reach a remarkable US$ 4.4 billion by 2029. This forecast represents a robust Compound Annual Growth Rate (CAGR) of 4.1% over the period.
The burgeoning market for non-opioid pain patches is being primarily fueled by several key factors. One significant driver is the profound socio-economic impact of pain, which surpasses the combined influence of diabetes, cancer, and cardiovascular diseases. This reality underscores the critical need for effective pain management solutions, propelling the demand for non-narcotic pain patches worldwide.
Get Sample Report Visit: https://www.futuremarketinsights.com/reports/sample/rep-gb-11286
Chronic pain, stemming from various sources such as back strain due to heavy lifting, accidents, or underlying medical conditions like arthritis, spine disease, and pancreatitis, is a pervasive issue driving market growth. As the incidence of chronic pain continues to rise, so does the demand for non-opioid alternatives, positioning pain patches as a preferred mode of relief.
Moreover, the increasing preference for non-opioid pain relief patches is attributed to their ability to mitigate the risk of addiction, particularly when compared to fentanyl patches, which release opioids over an extended period. This distinction is crucial in addressing the ongoing opioid crisis and fostering safer pain management practices globally.
Furthermore, the growing preference for minimally invasive treatments is expected to further bolster market expansion in the foreseeable future. Non-opioid pain patches offer a convenient and less invasive alternative to traditional pain management methods, driving adoption rates among healthcare providers and patients alike.
As the demand for effective, non-addictive pain relief solutions continues to escalate, the global non-opioid pain patches market is poised for sustained growth, presenting significant opportunities for industry players and stakeholders.
Key Takeaways of Non-opioids Pain Patches Market Study
- In terms of product type, the lidocaine patches segment is expected to capture over 65% of revenue share in the non-opioid pain patches market.
- Owing to superior topical effectiveness with minimal side-effects and prolonged transdermal drug release, lidocaine patches are the most preferred product type.
- In terms of distribution channel, hospital pharmacies and retail pharmacies & drug stores are expected to collectively hold over 70% of total value in the non-opioid pain patches market during the forecast period.
- North America is the highest revenue generating market by region, due to high R&D projects and conducive regulatory environment for non-opioid pain therapeutics. Europe is expected to offer lucrative opportunities, owing to the large aging population and increasing per capital healthcare expenditure.
Request Report Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-11286
Competition Landscape:
The predominant focus among key players in the global market for non-opioid pain patches revolves around developing topical patches devoid of addictive properties, catering to both chronic and acute pain relief needs. Efforts are directed towards improving skin adhesion and prolonging analgesic effects through innovative therapeutic alternatives. Additionally, select players are deeply invested in collaborative research endeavors with academic institutions to introduce fresh non-narcotic pain patch solutions.
For instance,
- In January 2021, a team of researchers led by Duke University unveiled a groundbreaking surgical patch designed to release non-opioid pain relievers directly to wound sites, providing sustained relief over several days before naturally dissolving. This innovative polymer patch administers a controlled dose of a medication capable of inhibiting the COX-2 enzyme, known for driving inflammation and pain.
- In July 2020, the U.S. Food and Drug Administration (FDA) granted approval for an 8% capsaicin patch targeted at alleviating neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults. This non-opioid, topical treatment represents a unique solution, delivering prescription-strength capsaicin directly to the skin without systemic effects, marking a significant advancement in pain management options.
Key Companies Profiled:
- Sanofi S.A.
- Pfizer Inc.
- GlaxoSmithKline Plc.
- Hisamitsu Pharmaceutical Co., Inc.
- Clarion Brands
- Endo Pharmaceuticals
- TEH SENG Pharmaceutical
- Veridian Healthcare
- Sorrento Therapeutics (SCILEX Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
- Teikoku Seiyaku Co. Ltd.
Non-opioid Pain Patches Market by Category:
Product Type:
- Lidocaine Patches
- Diclofenac Patches
- Methyl Salicylate Patches
- Capsaicin Patches
- Ketoprofen Patches
- Others
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa (MEA)
Purchasing this Report: https://www.futuremarketinsights.com/checkout/11286
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube